Paclitaxel, Carboplatin And Low Dose Radiation As Induction Therapy In Locally Advanced Head And Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Carboplatin
Related studies linked through entity extraction aliases.
Paclitaxel, Carboplatin and Radiotherapy as Induction Therapy in Locally Advanced Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
PH 1 Evaluation Of Oral CI-1033 In Combination With Paclitaxel/ Carboplatin As 1st Line Chemotherapy In NSCLC Patients
- Status
- COMPLETED
- Phase
- PHASE1
Taxol/ Carboplatin as First Line Therapy in Patients With Epithelial Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study for Patients With Non Small Cell Lung Cancer (NSCLC)
- Status
- UNKNOWN
- Phase
- PHASE2
Intensive Chemo-Radiotherapy With Peripheral Blood Progenitor Cell Rescue for Children With Advanced Neuroblastoma and Sarcomas
- Status
- COMPLETED
- Phase
- PHASE2
Pilot Study for the Determination of Tumor Response to Chemotherapy in Advanced NSCLC Through Gene Expression Profiling
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Paclitaxel/Carboplatin With or Without CDP791 in Patients With Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Trastuzumab (Herceptin), Paclitaxel, Carboplatin and Gemcitabine in Advanced Urothelial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Preoperative Herceptin/Navelbine Versus Taxotere/Carboplatin/Herceptin in HER-2 Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Randomized Phase III-Study in Stage IIIb and IV Non-Small-Cell Lung Cancer. Sequential Single-Agent vs. Double-Agent vs. Triple-Agent Therapy.
- Status
- COMPLETED
- Phase
- PHASE3
Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary Site
- Status
- TERMINATED
- Phase
- PHASE2
Combination Study Of CP-751,871 With Paclitaxel And Carboplatin In Advanced Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Determination of Carboplatin's Optimal Plasmatic Exposure
- Status
- COMPLETED
- Phase
- NA
Docetaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Ispinesib In Combination With Carboplatin In Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Paclitaxel, Carboplatin and Gemcitabine in the Treatment of Patients With Advanced Transitional Cell Cancer of the Bladder
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Docetaxel Plus Carboplatin in Patients With Hormone Refractory Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2